Similarly, in September 2010, another study rebuffed the use of Venlafaxine and Duloxetine as first-line treatment in major depression, but recommend them as a second line option.
Massachusetts Institute of Technology | World Health Organization | California Institute of Technology | National Institutes of Health | Art Institute of Chicago | Institute for Advanced Study | American Institute of Architects | Georgia Institute of Technology | National Health Service | Rensselaer Polytechnic Institute | Rochester Institute of Technology | Franklin Institute | Royal Institute of Technology | Pasteur Institute | Institute of Contemporary Arts | California Institute of the Arts | Institute of Electrical and Electronics Engineers | British Film Institute | United States Department of Health and Human Services | Pratt Institute | National Cancer Institute | Virginia Military Institute | Cato Institute | Australian Institute of Sport | Harvard School of Public Health | Patient Protection and Affordable Care Act | Illinois Institute of Technology | Curtis Institute of Music | American Institute of Aeronautics and Astronautics | Royal Institute of British Architects |